PATENT CLAIM ANALYSIS

Application Number: 16386183
Application Type: Utility
Filing Date: 2019-04
Publication Date: 2019-08
Patent Classification: ["424", "465000"]

Abstract:
Provided herein in some embodiments are pharmaceutical compositions comprising a prostacyclin (PGI2) receptor agonist selected from 2-(((1r,4r)-4-(((4-chlorophenyl)(phenyl)carbamoyloxy)methyl)cyclohexyl)methoxy)acetic acid (Compound 1) and pharmaceutically acceptable salts, solvates, and hydrates thereof, as disclosed herein. In some embodiments the pharmaceutical compositions comprise a compound selected from 2-(((1r,4r)-4-(((4-chlorophenyl)(phenyl)carbamoyloxy)methyl)cyclohexyl)methoxy)acetic acid (Compound 1), and pharmaceutically acceptable salts, solvates, and hydrates thereof, in an amount equivalent to a therapeutically effective amount of Compound 1, the composition having a release rate by weight of the compound in an aqueous medium that is one or more of release rates (a), (b) and (c) as disclosed herein. The compositions of the present invention are useful in the treatment of PGI2 related disorders, such as those disclosed herein.

Claim (Index 120):
The pharmaceutical composition of  claim 118 , wherein Compound 1 is present in an amount from about 0.01% to about 0.6% by weight of the pharmaceutical composition.

Metadata:
- Claim Count in Document: 79.0
- Percentile: 100.0
- Lexical Diversity: 2.39744
- Patent Class: 424.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['15605108', '16150350', '11897940', '11930644', '14841428']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7423751818302501
- 35 USC 102 Novelty (BERT): 0.5058053778226126
- Combined Prediction Score: 0.7187182014294863
- Mean Citation Score: 226.473242
- Max Citation Score: 230.45815
- Similarity Product: 147.7991218004942

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 0
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test